Triumvira Immunologics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 27, 2020
- Vertical
- Immunotherapy
- Funding URL
- View Funding Page
- Funding Amount:
- $55,000,000
Company Info
- Company Description
- Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.
- Market
- Cancer treatment
- Location
- Austin, Texas, USA
- Coinvestors
- Bloom Burton & Co, Centre for Commercialization of Cancer Immunotherapy, Leaps by Bayer, Northpond Ventures, Oceanpine Capital, Viva Biotech